Skip to main content
Research CombinationAnti-AgingRecoveryPreclinical EvidenceEducational · Not medical advice

Thymalin + Epithalon: Immune-Longevity Protocol

Both Thymalin and Epithalon are short bioregulatory peptides developed by Vladimir Khavinson and studied across decades of Russian gerontological research. Thymalin is associated with thymic peptide function and immune regulation in aging populations; Epithalon with pineal peptide activity, melatonin normalization, and telomere elongation. The combination is commonly referenced in longevity research for its dual immune-modulating and anti-aging mechanistic rationale.

2
Compounds
Preclinical
Evidence Level
2
Research Refs
Anti-Aging
Primary Goal

Mechanism

Compound 1Longevity

Thymalin

Thymic bioregulatory peptide researched for restoring immune surveillance, T-cell function, and neuroendocrine-immune communication in aging subjects.

+
Compound 2Longevity

Epithalon

Pineal tetrapeptide researched for telomerase activation, melatonin normalization, and extension of healthy lifespan across multiple experimental models.

Synergistic Effect

Dual-pathway activation

Thymalin × Epithalon

Safety Notes

Both peptides have multi-decade Russian research records with a favorable safety profile at studied doses. Most available evidence comes from open-label trials and animal studies; controlled human RCT data remains limited compared to Western pharmacological standards.

Research References

Per-component source; Khavinson laboratory — no formal combination RCT exists

Emerging

Peptide bioregulators: a new class of geroprotectors. 35 years of research

St. Petersburg: Aster 2009
Emerging

Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells

Bull Exp Biol Med 2003
Browse all →

⚠ Educational Use OnlyPeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.